Nurse Practitioner, Family · Reno, NV
NPI
1508101791
Since 2012
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1155 Mill St, Ground Floor, Tahoe Tower
Reno, NV, 89502
Phone (775) 982-6450
Groups this clinician bills Medicare through
Medicare paid, 2024
$31K
659 services
Medicare patients, 2024
356
Average age 75
Drug cost, 2024
$1.5M
5,279 prescriptions
Company payments, 2025
$128
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ashlee A Crawford was code 99214 (office e&m - established), 483 times for 331 patients. In total Ashlee A Crawford billed 659 services in 9 codes, and Medicare paid $31K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-11-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 483 | 331 | $55.79 | $27K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 130 | 123 | $10.72 | $1,393 |
| 99214 Office E&M - Established | Office | 18 | 18 | $70.62 | $1,271 |
By year: 2022 $22K for 370 services; 2023 $24K for 417 services; 2024 $31K for 659 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ashlee A Crawford prescribed most often to Medicare patients was Warfarin Sodium, with 704 prescriptions and refills. In total Ashlee A Crawford wrote 5,279 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Warfarin Sodium Generic | 704 | 1,868 | 299 | $15K |
| Rosuvastatin Calcium Generic | 340 | 965 | 138 | $6,463 |
| Atorvastatin Calcium Generic | 318 | 913 | 121 | $5,579 |
| Amlodipine Besylate Generic | 273 | 823 | 115 | $1,893 |
| Ezetimibe Generic | 271 | 789 | 118 | $9,756 |
| Losartan Potassium Generic | 256 | 706 | 93 | $3,433 |
| Repatha Sureclick Evolocumab | 256 | 593 | 82 | $332K |
| Eliquis Apixaban | 255 | 542 | 95 | $304K |
| Doxazosin Mesylate Generic | 167 | 508 | 62 | $3,447 |
| Telmisartan Generic | 165 | 384 | 59 | $6,621 |
| Xarelto Rivaroxaban | 161 | 357 | 70 | $190K |
| Spironolactone Generic | 136 | 393 | 58 | $1,681 |
| Metoprolol Succinate Generic | 95 | 282 | 35 | $1,908 |
| Praluent Pen Alirocumab | 92 | 190 | 26 | $93K |
| Olmesartan Medoxomil Generic | 89 | 271 | 37 | $2,655 |
Brand drugs: 1,242 claims; generic drugs: 4,024 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ashlee A Crawford $128 ($128 in general payments such as food, travel and fees) from 1 company. The largest payer was Novartis Pharmaceuticals Corporation with $128.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 2 | $128 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.